Bausch Health and Salix Pharmaceuticals settled outstanding intellectual property claims against their drug Xifaxan from generic drugmaker Actavis Laboratories.
The Latest
The Bruce and Cynthia Sherman Charitable Foundation awarded three 2018 Sherman Prizes to Pittsburgh-based UPMC's David Binion, MD, New York City-based Mount Sinai Hospitals' Jean-Frederic Colombel, MD, and Rochester, Minn.-based Mayo Clinic's Amy Lightner, MD.
RedHill Biopharma met with the FDA to discuss its drug for irritable bowel syndrome with diarrhea, Bekinda, following a positive phase 2 study.
SPH Analytics recognized Mackinaw (Mich.) Surgery Center for achieving an unparalleled level of patient satisfaction.
The Dialysis Vascular Access Coalition is urging Congress to block CMS' proposed cuts to reimbursement for vascular access services, saying the proposal threatens access to care for end-stage renal disease patients.
The World Health Organization released new cancer tracking numbers, finding colorectal cancer is the third most common cancer in the world and the second deadliest, CNN reports.
Medline's Outpatient Outcomes magazine outlined eight ways ASCs can streamline supply chain ordering with inventory management software.
Donald J. Martin, MD, is a gastroenterologist at Overland Park, Kan.-based Gastrointestinal Associates.
Here are seven updates on GI companies from the past week:
The CDC and The Joint Commission developed new infection control resources for outpatient orthopedic, podiatry and pain management settings.